DDrare: Database of Drug Development for Rare Diseases

L-tyrosine (DrugBank: Tyrosine, L-tyrosine)

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
111	Congenital myopathy	1

6. Parkinson disease [ 2,123 clinical trials, 2,046 drugs, (DrugBank: 324 drugs), 183 drug target genes, 198 drug target pathways]

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,123 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02259049 (ClinicalTrials.gov)	October 2014	3/10/2014	The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease	The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease	Blood Pressure	Dietary Supplement: L-tyrosine;Dietary Supplement: Sugar Pill	New York Institute of Technology	NULL	Completed	40 Years	84 Years	Both	6	Phase 0	United States

111. Congenital myopathy [ 7 clinical trials, 13 drugs, (DrugBank: 4 drugs), 1 drug target gene, 8 drug target pathways]

Searched query = "Congenital myopathy", "Nemaline myopathy", "Central core disease", "Minicore myopathy", "Myotubular myopathy", "Centronuclear myopathy", "Congenital fiber-type disproportion myopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 7 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02035501 (ClinicalTrials.gov)	January 2014	2/7/2013	Treatment of TNNT1-Myopathy With L-Tyrosine.	Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.	Nemaline Myopathy	Drug: L-Tyrosine;Drug: Placebo	Hadassah Medical Organization	NULL	Enrolling by invitation	N/A	20 Years	Both	10	Phase 2	Israel